Dacarbazine, Injection, USP, 200mg, vials packaged in individual cartons, Rx only, Manufactured ...
FDA Recall #D-0313-2015 — Class III — November 25, 2014
Product Description
Dacarbazine, Injection, USP, 200mg, vials packaged in individual cartons, Rx only, Manufactured by Hospira Australia 1 Lexia Place, Mulgrave, Victoria Australia 3170. NDC 61703-327-22.
Reason for Recall
Discoloration: Reconstituted solution may appear pink instead of colorless to pale yellow when stored per the labeled conditions.
Recalling Firm
Hospira Inc. — Lake Forest, IL
Classification
Class III — Not likely to cause adverse health consequences.
Product Type
Drugs
Product Quantity
3,306 vials
Distribution
Nationwide
Code Information
Lot #: B032223AA; Exp: July 2016
Status
Terminated
Voluntary / Mandated
Voluntary: Firm initiated